These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32635162)

  • 1. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis.
    Zehra M; Curry JC; Pillai SS; Lakhani HV; Edwards CE; Sodhi K
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes as mediators and biomarkers in fibrosis.
    Qin XJ; Zhang JX; Wang RL
    Biomark Med; 2020 Jun; 14(8):697-712. PubMed ID: 32643390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the clinical use of collagen as biomarker of liver fibrosis.
    Meurer SK; Karsdal MA; Weiskirchen R
    Expert Rev Mol Diagn; 2020 Sep; 20(9):947-969. PubMed ID: 32865433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues.
    Parola M; Pinzani M
    Mol Aspects Med; 2019 Feb; 65():37-55. PubMed ID: 30213667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical markers, extracellular components in liver fibrosis and cirrhosis.
    Bolarin DM; Azinge EC
    Nig Q J Hosp Med; 2007; 17(1):42-52. PubMed ID: 17688172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection.
    Zhang Q; Xu M; Qu Y; Li Z; Zhang Q; Cai X; Lu L
    Mol Med Rep; 2015 Oct; 12(4):5647-54. PubMed ID: 26299203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
    Khanam A; Saleeb PG; Kottilil S
    Cells; 2021 May; 10(5):. PubMed ID: 34064375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA.
    Tadokoro T; Morishita A; Masaki T
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics and liver fibrosis: identifying markers of fibrogenesis.
    Mas VR; Fisher RA; Archer KJ; Maluf DG
    Expert Rev Proteomics; 2009 Aug; 6(4):421-31. PubMed ID: 19681677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the effect of exosomes from different cells on liver fibrosis.
    Hu X; Ge Q; Zhang Y; Li B; Cheng E; Wang Y; Huang Y
    Biomed Pharmacother; 2023 May; 161():114415. PubMed ID: 36812711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects in non-invasive assessment of liver fibrosis: Liquid biopsy as the future gold standard?
    Lambrecht J; Verhulst S; Mannaerts I; Reynaert H; van Grunsven LA
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1024-1036. PubMed ID: 29329986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C.
    Stauber RE; Lackner C
    World J Gastroenterol; 2007 Aug; 13(32):4287-94. PubMed ID: 17708599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review.
    Gong Y; Yang Y
    Life Sci; 2020 Sep; 256():117909. PubMed ID: 32512009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of Liver Fibrosis.
    Pinzani M
    Dig Dis; 2015; 33(4):492-7. PubMed ID: 26159264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells.
    Devhare PB; Sasaki R; Shrivastava S; Di Bisceglie AM; Ray R; Ray RB
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.
    Gressner OA; Weiskirchen R; Gressner AM
    Clin Chim Acta; 2007 Jun; 381(2):107-13. PubMed ID: 17399697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular insights into uremic cardiomyopathy: cardiotonic steroids and Na/K ATPase signaling.
    Kennedy DJ; Malhotra D; Shapiro JI
    Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):3-14. PubMed ID: 17535729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of diagnostic techniques of hepatic fibrosis.
    Hassan S; Syed S; Kehar SI
    J Pak Med Assoc; 2014 Aug; 64(8):941-5. PubMed ID: 25252523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Regression of Cirrhosis.
    Saffioti F; Pinzani M
    Dig Dis; 2016; 34(4):374-81. PubMed ID: 27170391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells.
    Chen L; Yao X; Yao H; Ji Q; Ding G; Liu X
    FASEB J; 2020 Apr; 34(4):5178-5192. PubMed ID: 32061112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.